Ontology highlight
ABSTRACT: Background
Breast cancer is the most common cancer among women worldwide, and approximately 70% of breast cancers are hormone receptor-positive and express estrogen receptor-α (ERα) or/and progesterone receptor. ERα has been identified to promote the growth of primary breast cancer, however, it can also antagonize signaling pathways that lead to epithelial-mesenchymal transition (EMT), including transforming growth factor-β (TGF-β) signaling. miRNA alteration or dysfunction is involved in cancer development and progression. Although miR-1271 has identified as a tumor suppressor in various cancers, the role of miR-1271 in breast cancer is still limited.Methods
The effect of miR-1271 on breast cancer progression was investigated both in vitro and in vivo. The EMT-related prot
SUBMITTER: Liu BW
PROVIDER: S-EPMC6397493 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature